Oramed recieves $13.2M from Scilex, slashing Tranche A principal to $7.7M

ORAMED PHARMACEUTICALS INC.

Scilex paid ~$13.2M on Dec 13, 2024, satisfying the $15M installment due Dec 21.
Combined with prior payments, $94.2M of original $101.9M Tranche A Note has been repaid or refinanced.
Remaining Scilex debt to Oramed: $7.675M (Tranche A) and $25M (Tranche B Notes).
Payment stems from September 2023 securities purchase agreement and subsequent October 2024 refinancing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.